FDA Approved Medical Products for:

Thyroid cancer, medullary

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Vandetanib
Indication
The FDA has approved this product to be used in this manner.
Treatment of asymptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease
More Information about this product Drug Information Portal

Generic Name Cabozantinib
Trade Name
(Manufacturer Name)
Cometriq
(Exelixis, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of progressive, metastatic medullary thyroid cancer (MTC).
More Information about this product Drug Information Portal

Generic Name Thyrotropin alpha
Trade Name
(Manufacturer Name)
Thyrogen®
(Genzyme Corporation)
Indication
The FDA has approved this product to be used in this manner.
As an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with thyroid cancer.
More Information about this product Drug Information Portal